Astec LifeSciences Limited reported a significant decline in financial performance for Q2 FY25, with total income down 10.1% to Rs 100.5 crore compared to Q2 FY24, and an EBITDA loss of Rs 17.7 crore versus a loss of Rs 2.4 crore in the previous year
AI Assistant
Astec Lifesciences Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.